View in EDS

Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.

Saved in:
Bibliographic Details
Title: Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.
Authors: Riebenfeld D; Medical Department, Sanofi-Aventis (Schweiz) AG, Vernier, Switzerland., Spirk D; Medical Department, Sanofi-Aventis (Schweiz) AG, Vernier, Switzerland., Mathis A; Institut DiaMon, Baden Dättwil, Switzerland., Villiger L; Institut DiaMon, Baden Dättwil, Switzerland., Gerber PA; Klinik für Endokrinologie und Diabetologie, UniversitätsSpital Zürich, Switzerland., Gasser UE; ClinResearch Ltd, Aesch, Switzerland., Lehmann R; Klinik für Endokrinologie und Diabetologie, UniversitätsSpital Zürich, Switzerland.
Source: Swiss medical weekly [Swiss Med Wkly] 2015 Mar 05; Vol. 145, pp. w14114. Date of Electronic Publication: 2015 Mar 05 (Print Publication: 2015).
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Trägerverein Swiss Medical Weekly SMW Country of Publication: Switzerland NLM ID: 100970884 Publication Model: eCollection Cited Medium: Internet ISSN: 1424-3997 (Electronic) Linking ISSN: 00367672 NLM ISO Abbreviation: Swiss Med Wkly Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25741640
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Riebenfeld+D%22">Riebenfeld D</searchLink>; Medical Department, Sanofi-Aventis (Schweiz) AG, Vernier, Switzerland.<br /><searchLink fieldCode="AU" term="%22Spirk+D%22">Spirk D</searchLink>; Medical Department, Sanofi-Aventis (Schweiz) AG, Vernier, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mathis+A%22">Mathis A</searchLink>; Institut DiaMon, Baden Dättwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Villiger+L%22">Villiger L</searchLink>; Institut DiaMon, Baden Dättwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gerber+PA%22">Gerber PA</searchLink>; Klinik für Endokrinologie und Diabetologie, UniversitätsSpital Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gasser+UE%22">Gasser UE</searchLink>; ClinResearch Ltd, Aesch, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lehmann+R%22">Lehmann R</searchLink>; Klinik für Endokrinologie und Diabetologie, UniversitätsSpital Zürich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100970884%22">Swiss medical weekly</searchLink> [Swiss Med Wkly] 2015 Mar 05; Vol. 145, pp. w14114. <i>Date of Electronic Publication: </i>2015 Mar 05 (<i>Print Publication: </i>2015).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Trägerverein+Swiss+Medical+Weekly+SMW%22">Trägerverein Swiss Medical Weekly SMW </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>100970884 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1424-3997 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200367672%22">00367672 </searchLink><i>NLM ISO Abbreviation: </i>Swiss Med Wkly <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25741640
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4414/smw.2015.14114
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: w14114
    Titles:
      – TitleFull: Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Riebenfeld D
      – PersonEntity:
          Name:
            NameFull: Spirk D
      – PersonEntity:
          Name:
            NameFull: Mathis A
      – PersonEntity:
          Name:
            NameFull: Villiger L
      – PersonEntity:
          Name:
            NameFull: Gerber PA
      – PersonEntity:
          Name:
            NameFull: Gasser UE
      – PersonEntity:
          Name:
            NameFull: Lehmann R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 03
              Text: 2015 Mar 05
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1424-3997
          Numbering:
            – Type: volume
              Value: 145
          Titles:
            – TitleFull: Swiss medical weekly
              Type: main
ResultId 1